TLDR:
- XRP ETF developments include a Cryptex S-1/A that lists XRP as an eligible 4.36% index component, with a 4.41% indicated fund weight.
- The Cryptex Digital Market Cap ETF table puts XRP above Chainlink, Solana, and Avalanche, yet the proposed multi-asset product is still pre-effective.
- Listed Funds Trust moved the Teucrium 2x Short Daily XRP ETF effectiveness date to Oct. 11, though the filing does not set a debut date.
- The amendment gives no stated reason for the timing change and does not cite the CLARITY Act, Senate negotiations, or a regulatory decision.
XRP has appeared in two U.S. fund-registration updates that describe separate products and stages. A Sept. 11 pre-effective amendment for the Cryptex Digital Market Cap ETF lists XRP as an Eligible Component. This XRP ETF update gives XRP a 4.36% weight in the underlying Cryptex Digital Market Cap Index. The document does not signal that any shares have begun trading.
The same table places XRP above Chainlink, Solana, and Avalanche by index weight. It also shows a 4.41% prospective fund allocation after Cryptex applies its additional eligibility screens. Separately, Listed Funds Trust changed the effectiveness date for its Teucrium 2x Short Daily XRP ETF to Oct. 11. That amendment does not announce a trading date.
XRP ETF Update Gives XRP a 4.36% Cryptex Index Weight
The Cryptex Digital Market Cap ETF is designed to follow the components and weightings of its digital-asset index. It is a proposed multi-asset crypto product, rather than a single-asset XRP fund. The preliminary prospectus says the shares are intended for Nasdaq under the ticker BAGZ. It has not become effective.
The Sept. 11 filing presents the index composition as of Sept. 8. XRP carries a 4.36% index weight and a 4.41% indicated fund weight. Chainlink stands at 3.15%, Solana at 2.80%, and Avalanche at 2.13% within the index. Each appears as an eligible component in the table.
Bitcoin and Ethereum hold the largest index allocations, at 25.83% and 13.55%, respectively. The index contains 36 assets, while the proposed fund screen leaves 19 constituents. Those screens address the proposed product’s own listing and operational requirements. They can alter a constituent’s final fund allocation.
The XRP ETF filing does not mean the Commission has approved the Cryptex product. A pre-effective S-1/A is a registration and disclosure step before sales may begin. The proposed product must become effective and complete its exchange-listing process. It also must satisfy the terms set by its sponsor and service providers.
XRP ETF Short Fund Filing Moves Effectiveness to October 11
A separate Sept. 11 filing came from Listed Funds Trust, not from Cryptex. Post-Effective Amendment No. 606 covers the Teucrium 2x Short Daily XRP ETF. It designates Oct. 11, 2026, as the new effective date for a previously filed amendment. It also identifies the form as Amendment No. 608 under the Investment Company Act.
The XRP ETF document says its sole purpose is to delay the fund’s effectiveness. It gives no explanation for the change and names no scheduled first trading day. For that reason, the record does not support describing the action ads an SEC decision to delay a launch. The trust submitted an amendment that sets a later effective date under Rule 485(b).
The Teucrium fund seeks negative twice XRP’s daily return before fees and expenses. It uses financial instruments, including swaps, instead of directly shorting XRP. If XRP falls 3% in one trading day, the stated objective would target roughly a 6% gain before costs. Actual returns can differ from that target after expenses and compounding.
The XRP ETF product resets its exposure each day. Compounding and volatility can cause returns over longer periods to differ from negative twice XRP’s cumulative move. The prospectus warns that investors can lose money even when XRP declines over a longer period as daily results compound. It describes the fund as a short-term trading vehicle requiring active monitoring.
The September amendment does not cite the CLARITY Act, Senate negotiations, or political opposition. It incorporates earlier registration materials by reference and changes only the effective date. The filing provides no trading date, exchange symbol, or new investment strategy for the Teucrium fund.
